Robert J. Spiegel is Director of RenovoRx, Inc.. Currently has a direct ownership of 40,983 shares of RNXT, which is worth approximately $53,277. The most recent transaction as insider was on Jan 26, 2024, when has been sold 40,983 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41K
0% 3M change
n/a 12M change
Total Value Held $53,277

Robert J. Spiegel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2024
BUY
Open market or private purchase
-
40,983 Added 50.0%
40,983 Common Stock

Also insider at

GERN
GERON CORP Healthcare
AYLA
Ayala Pharmaceuticals, Inc. Healthcare
CYCC
Cyclacel Pharmaceuticals, Inc. Healthcare
ATNX
Athenex, Inc. Healthcare
ADXSD
Advaxis, Inc.
RJS

Robert J. Spiegel

Director
Buffalo, NY

Track Institutional and Insider Activities on RNXT

Follow RenovoRx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNXT shares.

Notify only if

Insider Trading

Get notified when an Renovo Rx, Inc. insider buys or sells RNXT shares.

Notify only if

News

Receive news related to RenovoRx, Inc.

Track Activities on RNXT